loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 208201 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Taro Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TARO (1)

    filter

    01 GEL;TOPICAL (1)

    filter

    01 RX (1)

    filter

    01 NAFTIFINE HYDROCHLORIDE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    NAFTIFINE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    GEL; TOPICAL
    2%
    2019-04-10
    208201
    NAFTIFINE HYDROCHL...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 208201

    Looking for FDA Orange Book APPLICATION 208201 1

    19

    Taro Pharmaceutical Industries, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is NAFTIFINE HYDROCHLORIDE, with a corresponding application number 208201.

    Regulatory Information RX

    With a dosage strength 2%

    Dosage Form Route GEL; TOPICAL

    Reference Listed Drug No

    Approved since 2019-04-10

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY